Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
- Источник
- Decrypt
- Опубликовано
- 2026-08-19 16:54 UTC
- Кэш обновлён
- 2026-08-19 17:01 UTC
Здесь показаны только заголовок, обзор и источник.
Открыть оригинал ↗Проверить комиссииСвязанные темы
01Users and Apps02Market and Policy
Decrypt
Follow consumer wallet, application, security, DeFi, and market updates before deciding whether Energy rental is needed.
Crypto Market, Regulation, and Stablecoin Policy News
Track crypto market, regulatory, stablecoin, and major-asset updates for broader blockchain context.